BioAtla BCAB
OTC BCAB
$1.50 -0.10 (-6.25%)
At close: Sep 29, 2026 · 4:00 PM EDT

BioAtla (BCAB) FCF Margin (2020 - 2026)

Updated

BioAtla's FCF Margin came in at -6.45% for Q2 2026.

Analysis

BioAtla (BCAB) FCF Margin (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, BioAtla reported FCF Margin of -276.26%, up 199.40 percentage points year-over-year; for FY2025, it was -2410.20%, down 1756.24 percentage points from FY2024.

  • FCF Margin carries a five-year change of +6196.79 percentage points (FY2020 to FY2025).
  • Going back by year, FCF Margin was -653.96% in FY2024 and -25255.20% in FY2021 (-16648.21 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 28.82%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 18.33%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 26.96%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 43.05%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 34.72%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 34.70%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 44.00%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.01%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 30.39%
10 BioAtla 2.49 Mn 2.49 Mn - -6.45%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.45%
Dec 31, 2025 -395.75%
Sep 30, 2024 -46.65%
Jun 30, 2021 -5,512.00%
Sep 30, 2020 -10,380.67%
Jun 30, 2020 -1,641.05%
Mar 31, 2020 -4,307.87%
API Access

BioAtla FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=BCAB&period=max&api_key=YOUR_API_KEY